// App-Quantinova.ai

OP0351 (2018) : First diagnosis of uveitis is not higher among juvenile idiopathic arthritis (JIA patients receiving etanercept compared to methotrexate

Researchers

Presenter

  • R. Davies

Principal Investigators

  • D. De Cock

  • L. Kearsley-Fleet

  • A. Ramanan

  • K.L. Hyrich

Medical Centers

  • Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University Of Manchester, Manchester, United Kingdom

  • Academic Rheumatology, University Hospitals Bristol NHS Foundation Trust

  • Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol

  • National Institute of Health Research Manchester Musculoskeletal Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Ophthalmology (OP)

Disease

  • Rheumatoid arthritis

  • Uveitis

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved